TY  - GEN
AU  - van Veggel,Bianca
AU  - de Langen,Adrianus J
AU  - Hashemi,Sayed
AU  - Monkhorst,Kim
AU  - Rosenberg,Efraim H
AU  - Heideman,Daniëlle A M
AU  - Radonic,Teodora
AU  - Smit,Egbert F
TI  - Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses
SN  - 1872-8332
PY  - 2019///0912
KW  - Aged
KW  - Anaplastic Lymphoma Kinase
KW  - antagonists & inhibitors
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Crizotinib
KW  - pharmacology
KW  - Drug Resistance, Neoplasm
KW  - ErbB Receptors
KW  - Female
KW  - Gene Amplification
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - genetics
KW  - Protein Kinase Inhibitors
KW  - therapeutic use
KW  - Proto-Oncogene Proteins c-met
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.lungcan.2018.07.030
ER  -